About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Knocking Opportunity Costs | Main | Speak for Themselves, They Do »

April 27, 2005

Experimental Update, For Those Who Care

Email This Entry

Posted by Derek

Well, I got the results of my experiments this afternoon. There might be something there, but I'll have to see the rest of the data in the morning to be a bit more sure. In research, we live for slam-dunk experiments that really prove things, but most of the time we get this could-be might-be stuff.

Most of the reactions did nothing, which was disappointing. Two of them showed what could be a real effect, though, and those two were from the same chemical class. That could be telling me something, or it could be just a coincidence. The analysis of some duplicate runs of the same things will be ready in the morning, and I'll see.

If they repeat, that's probably good news. I'll then simultaneously narrow down and fan out in other directions. That is, I'll set those same reactions up again, and add a few runs that are controlled for against some other variables. On the other hand, if they don't repeat, then I first need to make sure that my wonderful pipetting technique isn't one of the causes, but then I have some other things to try on different systems.

One of the few things I can prove is that not every system I can set up has an equal chance of working - in fact, some of them definitely won't work at all, for reasons that can't be foreseen. Perhaps I've landed on one of these and need to get out into another area - or perhaps I'm just wrong from the start. It's too early, fortunately, to be able to prove that.

UPDATE: Well, all the experiments repeated quite nicely, which is something to be glad of. If I'm wrong, I'm wrong the same way every time. I'm already planning another run of stuff for sometime next week, and I won't inflict the details on everyone until they're finished.

Comments (0) + TrackBacks (0) | Category: Birth of an Idea



Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry